Peroxisome proliferator activated receptor-γ modulates reactive oxygen species generation and activation of nuclear factor-κB and hypoxia-inducible factor 1α in allergic airway disease of mice
Peroxisome proliferator activated receptor-γ modulates reactive oxygen species generation and activation of nuclear factor-κB and hypoxia-inducible factor 1α in allergic airway disease of mice
复制标题
DOI:
10.1016/j.jaci.2006.03.021
复制
发表时间:
2006-07-01
影响因子:
14.2
通讯作者:
Lee, Yong Chul
中科院分区:
文献类型:
--
作者:
Lee, Kyung Sun;Kim, So Ri;Lee, Yong Chul
Background: Reactive oxygen species (ROSs) play a crucial role in the pathogenesis of airway inflammation. Peroxisome proliferator activated receptor (PPAR)-gamma is also involved in airway inflammation. We have demonstrated that the administration of PPAR gamma agonists or adenovirus carrying PPAR gamma cDNA (AdPPAR gamma) reduced bronchial inflammation and airway hyperresponsiveness. However, the effects of PPAR gamma on ROS generation in conditions associated with airway inflammation have not been clarified.Objective: This study aimed to investigate the effects of the PPAR gamma on ROS generation in allergic airway disease of mice.Methods: We have used a female C57BL/6 mouse model for allergic airway disease to determine the role of PPAR gamma.Results: In this study with an ovalbumin-induced murine model of allergic airway disease, the increased ROS generation and the increased expression of T(H)2 cell cytokines, adhesion molecules, chemokines, and vascular endothelial growth factor in lungs after ovalbumin inhalation were significantly reduced by the administration of PPAR gamma agonists or AdPPAR gamma. We also showed that the increased nuclear factor-kappa B and hypoxia-inducible factor let levels in nuclear protein extracts of lung tissues after ovalbumin inhalation were decreased by the administration of PPAR gamma agonists or AdPPAR gamma.Conclusion: These results indicate that the effects of PPAR gamma ire mediated by the modulation of ROS generation and activation of redox-sensitive transcription factor nuclear factor-kappa B and HIF-1 alpha in allergic airway disease of mice.Clinical implications: Thus, these findings provide a pivotal molecular mechanism for the use of PPAR gamma agonists to prevent and/or treat asthma and other airway inflammatory disorders.